베타
임상 레이더 AI
임상시험 NCT06744491 (NFRF)은(는) 신체 활동 부족, 노화, 건강한 노화, Growth & Development, 성차, Anabolic Sensitivity, Protein Metabolism, 신체 활동에 대해 대상자모집전 상태입니다. 모든 세부 정보를 보려면 임상시험 레이더 카드 뷰와 AI 발견 도구를 확인하거나 여기에서 무엇이든 물어보세요.
하나의 임상시험이 필터 기준과 일치합니다.
카드 뷰

Oral 'Breath Test' to Measure Anabolic Sensitivity to a Protein Meal Across the Age and Physical Activity Spectrum (NFRF)

대상자모집전
임상시험 세부 정보는 주로 영어로 제공됩니다. 하지만 임상 레이더 AI가 도와드릴 수 있습니다! '시험 설명하기'를 클릭하여 선택한 언어로 임상시험 정보를 확인하고, 이에 대해 AI와 논의해 보세요.
임상시험 NCT06744491 (NFRF)은(는) 신체 활동 부족, 노화, 건강한 노화, Growth & Development, 성차, Anabolic Sensitivity, Protein Metabolism, 신체 활동에 대해 알아보는 관찰연구입니다. 현재 상태는 대상자모집전이며, 2024년 12월 20일부터 참여 신청이 가능합니다. 80명의 참여자를 모집할 예정입니다. 토론토 대학교이(가) 진행하는 이 연구는 2025년 8월 31일까지 진행될 예정입니다. ClinicalTrials.gov의 가장 최근 정보는 2024년 12월 20일에 갱신되었습니다.
간단한 개요
The purpose of this study is to determine how anabolic sensitivity, in response to the ingestion of a liquid protein meal, differs across the lifespan, between biological sexes, and with varying physical activity levels.
상세한 설명
Skeletal muscle is a dynamic tissue that responds to anabolic (i.e., growth) stimuli such as protein ingestion and exercise. Differences in age and physical activity levels will influence an individual's ability to respond to these anabolic stimuli; this concept is known as anabolic sensitivity. For instance, older and less physically active individuals will display lower anabolic sensitivity (i.e., anabolic resistance) to a bout of exercise or the consumption of protein in comparison to younger, more physically active individuals. Seeing that individuals with anabolic resistance are at a greater risk for losing muscle mass over time, it is important to understand the anabolic sensitivity/resistance of an individual to assess for the efficiency of growth across the health and lifespan, in addition to a potential screen for metabolic alterations that could manifest into changes in lean body and muscle mass.

Traditional methods to assess for skeletal muscle anabolism and protein metabolism requires in-person and invasive research methods (i.e., stable isotope infusions and muscle biopsies) in controlled laboratory or clinical settings. However, there are many risks associated with these invasive procedures and they are not always feasible in all populations (e.g., children, clinical populations, etc..). Our lab has recently developed a non-invasive 13C breath test which employs an oral stable isotope tracer. Our breath test allows us to assess for anabolic sensitivity in response to protein ingestion, by determining how much of the ingested protein was used to build (synthesize) new proteins in our body (i.e., anabolism) or used as a source of energy (through a process called oxidation). As such, the purpose of the present study is to determine how anabolic sensitivity, in response to the ingestion of a liquid protein meal, differs across the lifespan and with varying physical activity levels.

공식 제목

Anabolic Sensitivity Across the Lifespan

질환/상태
신체 활동 부족노화건강한 노화Growth & Development성차Anabolic SensitivityProtein Metabolism신체 활동
기타 연구 식별자
  • NFRF
  • 00044004
NCT 번호
실제 연구 시작일
2024-12-20
최신 업데이트 게시
2024-12-20
예상 연구 완료일
2025-08-31
계획된 등록 인원
80
연구종류
관찰연구
상태
대상자모집전
키워드
anabolic sensitivity
aging
growth and development
physical activity
skeletal muscle
stable isotopes
시험군 / 개입
참가자 그룹/시험군개입/치료
Children
Children as defined by maturity offset via age from peak height velocity (aPHV \< -1.0 years).
해당 없음
Adolescent
Adolescents as defined by maturity offset via age from peak height velocity (aPHV -0.5 to +1.5 years)
해당 없음
Young Adults
Young adults as defined by chronological age between ages 18 - 35 years
해당 없음
Older Adults
Older adults as defined by chronological age between ages 60 - 80 years
해당 없음
주요결과변수
결과변수측정값 설명시간 범위
Amino acid oxidation and net protein balance
Amino acid oxidation and net protein balance assessed by oral 1-13C Leucine tracer. Net protein balance is derived from the difference between amino acid intake (known) and total amino acid oxidation over the 6h post-prandial measurement period.
6 Hours
적격성 기준

연령대
어린이, 성인, 노인
최소 연령
8 Years
참여 가능한 성별
전체
건강한 참가자 허용
  • Healthy will be defined as screened by the PAR-Q+ (The Physical Activity Readiness Questionnaire for everyone)
  • Chronological age for Healthy Young (age: 18-35 years) or Older (age: 60-80 years) adults
  • Chronological age between 8 to 16 years, with maturity offset < -1 year from age of Peak Height Velocity (aPHV) for children and between -0.5 to +1.5 years from aPHV in adolescent participants
  • BMI between normal to overweight (18.5 - 29.9 kg/m2)

  • Regular use of nonsteroidal anti-inflammatory dugs (with the exception of daily low-dose aspirin)
  • use of anticoagulants
  • use of a walker, cane, or assistive walking device
  • infectious or gastrointestinal disease
  • inability to comply with study protocol (e.g., unable to track diet)
  • regular tobacco use
  • self-reported illicit drug use (e.g., growth hormone, testosterone, etc.)
  • diagnosed chronic illness (e.g., type 2 diabetes, heart disease, thyroid disease)
  • pregnant
  • hormonal replacement therapy
연구 책임자
Daniel Moore, 책임연구자, Professor, Muscle Physiology, University of Toronto
연구 대표 연락처
연락처: Daniel R Moore, PhD, 4169464088, [email protected]
연락처: Hugo JW Fung, PhD Candidate, [email protected]
1 1개국에 임상시험 장소

Ontario

Goldring Center for High Performance Sport, Toronto, Ontario, M5S 2C9, Canada
Hugo JW Fung, PhD Candidate, 연락처, 416-946-5620, [email protected]